Discover

CTSO
Cytosorbents Corporation
5.75
2 x 4.15
2 x 7.61
bid
ask
-
0.01
0.17%
2 @ 04:00 PM
5.75 +0.00 (0.00%)
Ytd799.84%
1y516.29%
5.50
day range
6.00
5.13
52 week range
20.40
Open5.88Prev Close5.76Low5.50High6.00Mkt Cap18.12M
Vol11.77KAvg Vol11.54KEPS-5.80P/EN/AForward P/E-5.99
Beta0.56Short Ratio9.57Inst. Own33.29%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning11-1250-d Avg7.10200-d Avg10.901yr Est5.00
Income Statement
Total Revenue9.63M
Revenues (USD)9.63M
Cost of Revenue2.58M
Gross Profit7.05M
Operating Expenses9.69M
Research and Development Expense1.45M
Selling, General and Administrative Expense7.96M
Operating Income-2.64M
Interest Expense868.00K
Net Income-4.42M
Net Income Common Stock-4.42M
Net Income Common Stock (USD)-4.42M
Consolidated Income-4.42M
Earnings per Basic Share-1.40
Earnings per Basic Share (USD)-1.40
Earnings per Diluted Share-1.40
Earning Before Interest & Taxes (EBIT)-3.55M
Earning Before Interest & Taxes (USD)-3.55M
Weighted Average Shares3.14M
Weighted Average Shares Diluted3.14M
Balance Sheet
Cash and Equivalents5.94M
Cash and Equivalents (USD)5.94M
Trade and Non-Trade Receivables6.79M
Current Assets15.74M
Property, Plant & Equipment Net17.78M
Total Assets37.96M
Debt Current14.15M
Total Debt28.84M
Current Liabilities24.02M
Debt Non-Current14.69M
Total Liabilities38.71M
Accumulated Retained Earnings (Deficit)-321.75M
Accumulated Other Comprehensive Income-996.00K
Shareholders Equity-751.00K
Shareholders Equity (USD)-751.00K
Assets Non-Current22.22M
Total Debt (USD)28.84M
Goodwill and Intangible Assets2.86M
Inventory3.69M
Liabilities Non-Current14.69M
Trade and Non-Trade Payables2.00M
Cash Flow
Depreciation, Amortization & Accretion314.00K
Net Cash Flow / Change in Cash & Cash Equivalents-400.00K
Capital Expenditure45.00K
Net Cash Flow from Investing7.00K
Net Cash Flow from Operations-583.00K
Effect of Exchange Rate Changes on Cash 176.00K
Share Based Compensation368.00K